Öz
4. Aviña-Zubieta JA, Abrahamowicz M, De Vera MA, et al. Immediate and past cumulative effects of oral gluco- corticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheu- matology (Oxford) 2013;52:68-75
Anahtar Kelimeler
Kaynakça
- Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheu- matoid arthritis. Rheumatology (Oxford) 2013;52:45- 52.
- Koivuniemi R, Paimela L, Suomalainen R, et al. Cardio- vascular diseases in patients with rheumatoid arthri- tis. Scand J Rheumatol 2013;42:131-135.
- Hürlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz 2004;29:760-768.
- Aviña-Zubieta JA, Abrahamowicz M, De Vera MA, et al. Immediate and past cumulative effects of oral gluco- corticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheu- matology (Oxford) 2013;52:68-75.
- Trementino L, Arnaldi G, Appolloni G, et al. Coagu- lopathy in Cushing’s syndrome. Neuroendocrinology 2010;92(Suppl 1):55-59.
Öz
Cardiovascular involvement is common in rheumatoid arthritis [1]. Pericarditis, cardiomyopathy, myocarditis, cardiac amyloidosis, coronary vasculitis, arrhythmias, valvular heart disease and congestive heart failure due to ischemia can be seen in addition to the classical extra-articular involvement [2]. Patients with rheumatoid arthritis are under risk of accelerated atherosclerosis and myocardial infarction due to increased inflammation. Endothelial dysfunction is an important mechanism for thrombosis in these patients [3]. Pro-inflammatory cytokines (interleukin-1 beta and tumor necrosis factor alpha, C-reactive protein), activated coagulation factors (tissue factor, von Willebrand factor and plasminogen activator inhibitor-1), increased activity of cell adhesion molecules (selectins, vascular adhesion molecule-1, intercellular adhesion molecule-1) and matrix metalloproteinases are responsible for this endothelial dysfunction leading thrombosis [3]. The risk is especially higher in patients who have used or are using glucocorticoids [4]. In patients with Cushing\'s syndrome due to chronic steroid use, accumulation of cardio-metabolic risk factors like visceral obesity, hypertension, hyperglycemia and hyperlipidemia results in acceleration of cardiovascular disease [4]. Additionally, a hypercoagulability state was also detected in patients with endogenous Cushing\'s syndrome [5]. Herein we present a patient with rheumatoid arthritis who had extensive coronary thrombosis and was given steroid therapy for a long time. J Clin Exp Invest 2013; 4 (4): 568-569
Anahtar Kelimeler
Kaynakça
- Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheu- matoid arthritis. Rheumatology (Oxford) 2013;52:45- 52.
- Koivuniemi R, Paimela L, Suomalainen R, et al. Cardio- vascular diseases in patients with rheumatoid arthri- tis. Scand J Rheumatol 2013;42:131-135.
- Hürlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz 2004;29:760-768.
- Aviña-Zubieta JA, Abrahamowicz M, De Vera MA, et al. Immediate and past cumulative effects of oral gluco- corticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheu- matology (Oxford) 2013;52:68-75.
- Trementino L, Arnaldi G, Appolloni G, et al. Coagu- lopathy in Cushing’s syndrome. Neuroendocrinology 2010;92(Suppl 1):55-59.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Editöre Mektup |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Aralık 2013 |
| Yayımlandığı Sayı | Yıl 2013 Cilt: 4 Sayı: 4 |